00512 GRAND PHARMA
Trading Add to Porfolio| Index Constituent : HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, Stock Connect HK Ind, Stock Connect HK MS | |||
| Major Shareholders | Hu Kaijun & Associates (56.32%) CDH Fund V, L.P. (8.62%) |
Sector | Health Care & Biotechnology |
|---|---|---|---|
| Web Site | https://www.grandpharma.cn/ | Tel | N/A |
| ir@chinagrandpharm.com | Fax | N/A | |
| Related Equities | N/A | ||
| Principal Activities | Principally engaged in the manufacture and sales of pharmaceutical preparations and medical devices, bio-technology products and nutrition products, specialized pharmaceutical raw materials and other products, in the People's Republic of China (the PRC). | ||
Consolidated List of Substantial Shareholders
| Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|---|---|---|
| 周彤 | 2,344,125,206(L) | 74.78(L) | 03/10/2018 |
| 胡凱軍 | 2,344,125,206(L) | 74.78(L) | 03/10/2018 |
| 上海遠大產融投資管理有限公司 | 523,456,057(L) | 16.70(L) | 03/10/2018 |
| China Diamond Holdings Company Limited | 356,648,142(L) 108,408,000(S) | 11.90(L) 3.62(S) | 12/09/2018 |
| Assicurazioni Generali S.p.A | 281,875,959(L) | 8.99(L) | 13/11/2018 |
| Li Zhenfu | 281,875,959(L) | 8.99(L) | 13/11/2018 |
| GL Partners Capital Management Ltd. | 225,639,959(L) | 7.20(L) | 13/11/2018 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
| Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
